MCL1 and melanoma: Regarding research in this direction, previously it had been stated that BH3-mimetic MIM1 (4-((E)-((Z)-2-(cyclohexylimino)-4-methylthiazol-3(2H)-ylimino)methyl) benzene 1,2,3-triol), which inhibits the Mcl-1 antiapoptotic protein, may be an efficacious molecule able to induce apoptosis and sensitize melanomas [7,8], as well as glioblastoma multiforme [9] cells, to alkylating agents—dacarbazine (DTIC) and temozolamide.